Successful translation of basic stem cell (SC) research into
commercially viable therapeutic applications relies on the ability to
manipulate human cells suitable for regenerative medicine under animal
product free conditions.
The challenge remains to create serum-free systems in which SCs for
human therapy can be placed in a microenvironment for optimal growth and
differentiation without the risk of introducing viruses and
animal-related pathogens.
Local scientists are currently researching what may progress this
challenge; the extracellular matrix (ECM), a dynamic biological support
structure around cells of all tissues and organs in the human body ebwana.
SC-development depends on communication with the ECM through
signaling, be it in the human body or in lab-based experimental models
like cell culture systems.
According to Professsor Deirdr
...
Read more »